Entry of equid herpesvirus 1 into CD172a+ monocytic cells
- Author
- Kathlyn Laval (UGent) , Herman Favoreel (UGent) , Jolien Van Cleemput (UGent) , Katrien Poelaert (UGent) , Ivy Brown, Bruno Verhasselt (UGent) and Hans Nauwynck (UGent)
- Organization
- Abstract
- Equid herpesvirus 1 (EHV-1) causes respiratory disease, abortion and neurological disorders in horses. Cells from the myeloid lineage (CD172a(+)) are one of the main target cells of EHV-1 during primary infection. Recently, we showed that EHV-1 restricts and delays its replication in CD172a(+) cells as part of an immune-evasive strategy to disseminate to target organs. Here, we hypothesize that a low efficiency of EHV-1 binding to and entry in CD172a(+) cells is responsible for this restriction. Thus, we characterized EHV-1 binding and entry into CD172a(+) cells, and showed that EHV-1 only bound to 15-20 % of CD172a(+) cells compared with 70 % of RK-13 control cells. Enzymic removal of heparan sulphate did not reduce EHV-1 infection, suggesting that EHV-1 does not use heparan sulphate to bind and enter CD172a(+) cells. In contrast, we found that treatment of cells with neuraminidase (NA) reduced infection by 85-100 % compared with untreated cells, whilst NA treatment of virus had no effect on infection. This shows that sialic acid residues present on CD172a(+) cells are essential in the initiation of EHV-1 infection. We found that alpha(V)beta(3) integrins are involved in the post-binding stage of CD172a(+) cell infection. Using pharmacological inhibitors, we showed that EHV-1 does not enter CD172a(+) cells via a clathrin- or caveolae-dependent endocytic pathway, nor by macropinocytosis, but requires cholesterol, tyrosine kinase, actin, dynamin and endosomal acidification, pointing towards a phagocytic mechanism. Overall, these results show that the narrow tropism of EHV-1 amongst CD172a(+) cells is determined by the presence of specific cellular receptors.
- Keywords
- HERPES-SIMPLEX-VIRUS, DEPENDENT ENDOCYTIC PATHWAY, RECEPTOR-BINDING PROPERTIES, RAFT-MEDIATED ENDOCYTOSIS, HEPARAN-SULFATE, SIALIC-ACID, GLYCOPROTEIN C, INFLUENZA HEMAGGLUTININ, HUMAN CYTOMEGALOVIRUS, INFECTION REQUIRES
Downloads
-
(...).pdf
- full text (Published version)
- |
- UGent only
- |
- |
- 584.64 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8506076
- MLA
- Laval, Kathlyn, et al. “Entry of Equid Herpesvirus 1 into CD172a+ Monocytic Cells.” JOURNAL OF GENERAL VIROLOGY, vol. 97, no. 3, 2016, pp. 733–46, doi:10.1099/jgv.0.000375.
- APA
- Laval, K., Favoreel, H., Van Cleemput, J., Poelaert, K., Brown, I., Verhasselt, B., & Nauwynck, H. (2016). Entry of equid herpesvirus 1 into CD172a+ monocytic cells. JOURNAL OF GENERAL VIROLOGY, 97(3), 733–746. https://doi.org/10.1099/jgv.0.000375
- Chicago author-date
- Laval, Kathlyn, Herman Favoreel, Jolien Van Cleemput, Katrien Poelaert, Ivy Brown, Bruno Verhasselt, and Hans Nauwynck. 2016. “Entry of Equid Herpesvirus 1 into CD172a+ Monocytic Cells.” JOURNAL OF GENERAL VIROLOGY 97 (3): 733–46. https://doi.org/10.1099/jgv.0.000375.
- Chicago author-date (all authors)
- Laval, Kathlyn, Herman Favoreel, Jolien Van Cleemput, Katrien Poelaert, Ivy Brown, Bruno Verhasselt, and Hans Nauwynck. 2016. “Entry of Equid Herpesvirus 1 into CD172a+ Monocytic Cells.” JOURNAL OF GENERAL VIROLOGY 97 (3): 733–746. doi:10.1099/jgv.0.000375.
- Vancouver
- 1.Laval K, Favoreel H, Van Cleemput J, Poelaert K, Brown I, Verhasselt B, et al. Entry of equid herpesvirus 1 into CD172a+ monocytic cells. JOURNAL OF GENERAL VIROLOGY. 2016;97(3):733–46.
- IEEE
- [1]K. Laval et al., “Entry of equid herpesvirus 1 into CD172a+ monocytic cells,” JOURNAL OF GENERAL VIROLOGY, vol. 97, no. 3, pp. 733–746, 2016.
@article{8506076, abstract = {{Equid herpesvirus 1 (EHV-1) causes respiratory disease, abortion and neurological disorders in horses. Cells from the myeloid lineage (CD172a(+)) are one of the main target cells of EHV-1 during primary infection. Recently, we showed that EHV-1 restricts and delays its replication in CD172a(+) cells as part of an immune-evasive strategy to disseminate to target organs. Here, we hypothesize that a low efficiency of EHV-1 binding to and entry in CD172a(+) cells is responsible for this restriction. Thus, we characterized EHV-1 binding and entry into CD172a(+) cells, and showed that EHV-1 only bound to 15-20 % of CD172a(+) cells compared with 70 % of RK-13 control cells. Enzymic removal of heparan sulphate did not reduce EHV-1 infection, suggesting that EHV-1 does not use heparan sulphate to bind and enter CD172a(+) cells. In contrast, we found that treatment of cells with neuraminidase (NA) reduced infection by 85-100 % compared with untreated cells, whilst NA treatment of virus had no effect on infection. This shows that sialic acid residues present on CD172a(+) cells are essential in the initiation of EHV-1 infection. We found that alpha(V)beta(3) integrins are involved in the post-binding stage of CD172a(+) cell infection. Using pharmacological inhibitors, we showed that EHV-1 does not enter CD172a(+) cells via a clathrin- or caveolae-dependent endocytic pathway, nor by macropinocytosis, but requires cholesterol, tyrosine kinase, actin, dynamin and endosomal acidification, pointing towards a phagocytic mechanism. Overall, these results show that the narrow tropism of EHV-1 amongst CD172a(+) cells is determined by the presence of specific cellular receptors.}}, author = {{Laval, Kathlyn and Favoreel, Herman and Van Cleemput, Jolien and Poelaert, Katrien and Brown, Ivy and Verhasselt, Bruno and Nauwynck, Hans}}, issn = {{0022-1317}}, journal = {{JOURNAL OF GENERAL VIROLOGY}}, keywords = {{HERPES-SIMPLEX-VIRUS,DEPENDENT ENDOCYTIC PATHWAY,RECEPTOR-BINDING PROPERTIES,RAFT-MEDIATED ENDOCYTOSIS,HEPARAN-SULFATE,SIALIC-ACID,GLYCOPROTEIN C,INFLUENZA HEMAGGLUTININ,HUMAN CYTOMEGALOVIRUS,INFECTION REQUIRES}}, language = {{eng}}, number = {{3}}, pages = {{733--746}}, title = {{Entry of equid herpesvirus 1 into CD172a+ monocytic cells}}, url = {{http://doi.org/10.1099/jgv.0.000375}}, volume = {{97}}, year = {{2016}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: